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SUMMARY STATEMENT 
Novel cell penetrating peptide-calmodulin adaptor proteins effect efficient delivery of user-defined 
cargo proteins to the cytoplasms of living mammalian cells. 
‡ John Salerno passed away on Dec. 25, 2015. 





















The use of cell penetrating peptides (CPPs) as biomolecular delivery vehicles holds great 
promise for therapeutic and other applications, but development has been stymied by poor 
delivery and lack of endosomal escape. We have developed a CPP-adaptor system capable of 
efficient intracellular delivery and endosomal escape of user-defined protein cargos. The cell 
penetrating sequence of HIV transactivator of transcription was fused to calmodulin, which binds 
with subnanomolar affinity to proteins containing a calmodulin binding site. Our strategy has 
tremendous advantage over prior CPP technologies because it utilizes high affinity noncovalent, 
but reversible coupling between CPP and cargo. Three different cargo proteins fused to a 
calmodulin binding sequence were delivered to the cytoplasm of eukaryotic cells and released, 
demonstrating the feasibility of numerous applications in living cells including alteration of 






















In recent years a number of peptides that are rapidly internalized by mammalian cells have 
been discovered or designed (Fonseca, et al., 2009; Sebbage, 2009; Johnson, et al., 2011). Cell-
penetrating peptides (CPPs) are capable of mediating penetration of the plasma membrane, 
allowing delivery of macromolecular cargos to which they are attached to cell interiors. CPPs are 
typically 10 to 30 amino acids long and fall into one of three major categories: arginine-rich, 
amphipathic and lysine-rich, and hydrophobic (Gautam, et al., 2012). CPP delivery of cargos to 
the interior compartments of cells is potentially transformative as a research tool, diagnostic aid 
and therapeutic mechanism.  
More than 25 CPP clinical trials are underway, including a Phase III (Glogau, et al., 2012; 
Lonn and Dowdy, 2015). However, CPPs have largely disappointed (Palm-Apergi, et al., 2012) 
for a variety of reasons including nonpenetration (Lundberg, et al., 2003), limited endosomal 
escape (Erazo-Oliveras, et al., 2012), and requirements for hydrophobic cargos (Hirose, et al., 
2012). Described CPP technologies are reliant on covalent crosslinking or nonspecific 
hydrophobic interactions (Koren and Torchilin, 2012).  
The work described herein describes a novel technology that solves or ameliorates all of 
these problems. We have designed a CPP-adaptor fusion protein, TAT-Calmodulin (TAT-CaM), 
which noncovalently binds, delivers and releases cargo into the cytoplasm. Three different cargo 
proteins were chosen to reflect a range of characteristics including size, oligomerization and 
structure. The strategy is generally applicable to any soluble protein and may also be used to 
deliver nonprotein cargos such as RNA. Assays can be performed in real time with live cells 
without significant cytotoxicity and offers an alternative to transfection. Our advance greatly 





















RESULTS & DISCUSSION 
Schematics of the CPP-adaptor and cargo proteins are shown in Fig. 1A. Our prototype 
CPP-adaptor, TAT-CaM, consists of the cell penetrating sequence from the HIV transactivator of 
transcription (Green and Lowenstein, 1988) fused to calmodulin (CaM). Calmodulin was selected 
as the prototype adaptor not only because it binds its partners with high affinity in the presence 
of calcium, but also because mammalian cells typically maintain low resting cytoplasmic Ca2+ 
levels, allowing rapid release of cargo after internalization as affinity of CaM for its ligands is 
negligible in the absence of Ca2+. Cargos are fused to a N-terminal CaM binding sequence (CBS) 
encoded by the vector. 
The affinity of TAT-CaM for a natural ligand was first examined. TAT-CaM bound to 
neuronal nitric oxide synthase (nNOS) via the native CaM binding site with affinity similar to wild-
type CaM as assayed with biolayer interferometry (BLI), an optical biosensing technique similar 
to surface plasmon resonance (Fig. 1B) (Abdiche, et al., 2008; Sultana and Lee, 2015; McMurry, 
et al., 2011). Model cargos were then examined for CaM binding affinity and kinetics. Cargos 
myoglobin (CBS-Myo), horse radish peroxidase (CBS-HRP) and β-galactosidase (CBS-β-Gal) all 
bound CaM with low nanomolar affinity and expected fast-on, slow off kinetics (Fig. 1C-E). TAT-
CaM and cargo proteins dissociated rapidly upon exposure to EDTA (koff ~ 0.1 s-1, Fig. 1F), 
indicating that the TAT-CaM-CBS interactions function essentially indistinguishably from those of 
wild type CaM. All analytes exhibited negligible binding to sensors without TAT-CaM. Rate and 
affinity constants determined from single-state global fits are listed in Table 1. 
1 µM each of TAT-CaM and fluorescently-labelled cargo protein in buffer containing 1 mM 
CaCl2 were added to subconfluent BHK21 cells and incubated for 1 hour, after which cells were 
washed and imaged by fluorescence confocal microscopy. Uptake of cargo into cell interiors was 
assayed using an inverted Zeiss (Jena, Germany) LSM700 confocal microscope equipped with a 




















were acquired and analyzed for incorporation of fluorescently labeled cargo into the cytoplasm. 
Orthogonal projections of Z-stacks were generated using Zeiss ZEN software, which allowed for 
viewing both treated and untreated cells alike at the same depth within the cell relative to the 
diameter of the nucleus. As shown in Fig. 2, all cargo proteins were delivered to the interiors of 
the cells and showed significant cytoplasmic distribution, indicating efficient penetration and 
escape from endosomes. The fluorescently labelled cargo proteins without TAT-CaM showed a 
very small degree of adherence to the surfaces of cells, but no penetration into the cell as 
observed by absence of fluorescence at the same cytoplasmic depth as that observed in cells 
treated with TAT-CaM (Fig 2A-C). Cargos reflect an array of characteristics, e.g. myoglobin is 
small, all-alpha helical and monomeric while β-galactosidase is large, structurally complex and 
forms a 464 kDa tetramer (Jacobson, Zhangand, 1994). TAT-CaM delivers all cargos yet 
examined, including nNOS (data not shown). 
To demonstrate broad utility of cargo uptake in different types of cells, subconfluent HEK 
and HT-3 cells were treated with CBS-myoglobin cargo under identical conditions, and assayed 
using the same conditions as above (Figure 3).  HT-3 is a human retinoblastoma line of cervical 
type cells and HEK cells are human, embryonic and have an epithelial morphology whereas BHK 
cells have fibroblast morphology. As observed with BHK cells, CBS-myoglobin was also delivered 
to the interior of these different mammalian cell lines, indicating that cargo delivery can occur 
regardless of cell type used. 
Other CPP-cargo strategies rely on covalent linkage or nonspecific hydrophobic linkers 
that are susceptible to getting trapped by membrane association as the CPP itself may not be 
released into the cytoplasm. Even non-hydrophobic CPPs are likely to be tightly bound to 
membrane proteins involved in endocytosis or transmembrane translocation, which would be 
expected to greatly hinder endosomal escape by covalently attached cargo proteins. One group 




















Our strategy of high-affinity but reversible noncovalent attachment of cargos overcomes trapping 
effects via Ca2+-dependent dissociation, allowing rapid and efficient cargo distribution to the 
cytoplasm even though TAT may remain trapped in the endosome.  
Cytotoxicity is also a major drawback with current CPPs, particularly given the 
concentrations necessary to attain observable endosomal escape. Cytotoxic effects of TAT 
become significant in the tens of µM (Cardozo, et al., 2007). That TAT-CaM effects significant 
cytoplasmic distribution of cargos at 1 µM without an increase in cell death as measured by Trypan 
Blue exclusion (data not shown) is particularly exciting.  
The time frame of cargo delivery using CPP-adaptors is under an hour, and likely much 
faster. This is in stark contrast to the time needed to transfect cells; CPP-adaptor delivery is 
roughly two orders of magnitude faster than transfection, making possible time course 
experiments that could not previously be attempted.  
The array of applications made possible by our method is vast. For example, CPP-
adaptors can be developed that allow for subcellular addressing, e.g. delivery of a transcription 
factor to the nucleus. Delivery of antibodies, enzymes, nucleic acids and small molecules are all 
potentially transformative methods. Follow-up studies to address kinetics, dosing, toxicity and 





















MATERIALS & METHODS 
Expression and purification. Our prototype CPP-adaptor, TAT-CaM, (New Echota 
Biotechnology, Kennesaw, GA, USA), is encoded by a pET19b-based vector containing a 
cleavable His-tag, the cell penetrating sequence from the HIV transactivator of transcription 
(Green and Lowenstein, 1988) fused to calmodulin via a GGR linker. TAT-CaM was expressed 
and purified from E. coli BL21(DE3)pLysS using metal affinity chromatography essentially as 
described (McMurry, et al., 2015). Cargo proteins were expressed in BL21(DE3)pLysS from 
synthetic, E. coli optimized genes cloned into pCal-N-FLAG-based plasmids (Agilent 
Technologies, CA, USA), which contain vector-encoded N-terminal calmodulin binding 
sequences. Cargos were purified to near homogeneity using a calmodulin sepharose column (GE 
Life Sciences, Pittsburgh, PA, USA) and dialyzed into binding buffer (10 mM HEPES, pH 7.4, 150 
mM NaCl, 10% glycerol, 1 mM CaCl2, 1 mM DTT). Cargos were myoglobin (CBS-Myo, from 
Accession #AH002877), horse radish peroxidase (CBS-HRP, E01651) and β-galactosidase 
(CBS-β-Gal, M22590). Neuronal nitric oxide synthase was expressed and purified as described 
(Gerber, et al.. 1995; Roman, et al., 1995) and exchanged into binding buffer as above. For cell 
penetration assays, cargo proteins were labelled with DyLight 550 (Thermo Fisher, USA) 
according to the manufacturer’s protocol. Unreacted label was removed via a dye binding column. 
Biolayer interferometry. BLI experiments were performed using a FortéBio (Menlo Park, 
CA, USA) Octet QK using SA sensors. Assays were done in 96 well plates at 250 C.  200µL 
volumes were used in each well. Ligands were loaded onto sensors for 300-900 s followed by 
baseline measurements in binding buffer for 300 s. Association was measured by dipping sensors 
into solutions of analyte protein and was followed by moving sensors to buffer only to monitor 





















Cell penetration assays. 1 µM each of TAT-CaM and DyLight 550-labelled cargo protein 
in binding buffer were added to subconfluent BHK21 (authenticated line purchased from ATCC 
(#CCL-10) in 2010; frozen aliquots were expanded for assays), human embryonic kidney (HEK, 
gift from David Fulton, Medical College of Georgia) or HT-3 (purchased in 2015 from ATCC, 
#HTB-32) cells and incubated for 1 hour, after which cells were washed three times in phosphate 
buffered saline with 1 mM CaCl2. Following treatment with 2M CellTracker Green CMFDA Dye 
(ThermoFisher) to label the cytoplasmic compartment, cells were labelled with NucBlue 
(ThermoFisher) and transferred to media containing 25 mM HEPES, pH 7.4 for imaging. Cells 
were immediately imaged on an inverted Zeiss LSM700 Confocal Microscope equipped with a 
40x EC Plan-Neofluar objective (NA=1.3).  Pinholes for each fluorophore were set at 1.0 Airy 
Units (29 microns).  SP 490 and LP 615 filters were used to acquire the NucBlue (Blue channel) 
and DyLight 550 (Red Channel) signals, respectively.  CellTracker Green signal (Green channel) 
was acquired using a BP 490-555 filter. Filters were carefully chosen to minimize spectral overlap 
between DyLight and CellTracker Green signals at the expense of some decline in signal quality. 
Z-stacks for both TaT-CaM- treated and untreated cells were set by using the NucBlue 
staining of the nucleus as a reference (typical Z-stacks ranged from 6.0-10.0 microns).  Both 
treated and untreated cells were imaged at identical gain settings, set at sub-saturation levels on 
cells treated with TaT-CaM in the red emission (DyLight 550 fluorescence). Both treated and 
untreated cells were imaged at an identical laser output level (2.0%, 555 nm laser), identical pixel 
dwell time of 3.15 microseconds, and 2x line averaging.   
For analysis, images were rendered using the Orthogonal View in Zen Blue (Zeiss) 
software. Using the diameter of the nucleus as a landmark, the Z-plane chosen for analysis 
corresponded to approximately the mid-point depth of the nucleus. The DyLight 550 signal was 
analyzed separately (Figures 2 and 3, left panel, white signal), and merged with NucBlue (Figure 




















channel was included to aid in visualization of the cytoplasmic compartment in treated and 
untreated cells. 
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Figure 1. TAT-CaM cargo protein design and binding. (A) Schematic of TAT-CaM and 




















binding to (B) purified neuronal nitric oxide synthase. (C) CBS-β-Gal; (D) CBS-HRP; and (E) CBS-
myoglobin. TAT-CaM was biotinylated and bound to streptavidin (SA) sensors. Reference-
subtracted raw data are rendered as points with fits to a global single-state association-then-
dissociation model. Analyte concentrations are noted for each trace. Association and dissociation 
phases were 300s in length. (F) After dissociation in buffer only, sensors were moved to buffer 
containing 10 mM EDTA. The rapid dissociation phases of the 1 µM samples for each cargo 













































Figure 2. Confocal imaging of cell penetration. BHK cells were treated for 1 hour with 
DyLight 550 fluorescently labeled cargo proteins myoglobin (A), HRP (B) and B-Gal (C) (rendered 
as white in left panel, red in center and right panels), in either the absence or presence of TAT-
CaM, washed and imaged live. Center images presented are optical sections set at a similar 
depth of the nucleus (NucBlue staining, white, center and right panel), as determined by position 
within the Z-stack. Orthogonal projections (boxed in red and green, respectively) are shown at 
the right and top sides of each panel. Cytoplasmic compartments in live cells were visualized 
using CellTracker Green CMFDA dye (green in right panel).  Comparison of TAT-CaM-treated vs. 
untreated cells indicates that cargo proteins are entering into the cell, and are localized primarily 
to the cytoplasm.  Scale bars in all panels = 20 μm. Each experiment was replicated at least twice 












































Figure 3. Cargo delivery occurs in various mammalian cell lines. HEK (A), and HT-3 
(B) cells were treated for 1 hour with DyLight 550 fluorescently labeled CBS-myoglobin protein 
(white in left panel, red in center and right panels), in either the absence or presence of TAT-CaM, 
washed and imaged live. Orthogonal projections and center images that are optical sections set 
at a similar depth of the nucleus (NucBlue staining, white, right panel), as determined by position 
within the Z-stack are shown as in Fig. 2. Cytoplasmic compartments in live cells were visualized 
using CellTracker Green CMFDA dye (green in right panels).  Comparison of TAT-CaM-treated 
vs. untreated cells indicates that cargo proteins are able to enter various mammalian cell types.  






















 KD (nM) kon (M-1 s-1) koff  (s-1) koff (EDTA) (s-1) 
nNOS 15 1.2 x 104 1.8 * 10-4 ND 
β-Gal 73 9.2 x 103 6.7 * 10-4 0.05 
HRP 160 1.7*103 2.8 * 10-4 0.2 
Myo 0.9 5.9 x 104 5.5 * 10-5 0.09 
 
Table 1. Kinetic parameters for sensorgrams shown in Fig. 1. ND, not determined but previously 
reported to be ~0.1 s-1 (McMurry, et al., 2011). 
 
